Journal: Diagnostic Microbiology and Infectious Disease
Article Title: The Biofire® Filmarray® Pneumonia Plus panel for management of lower respiratory tract infection in mechanically-ventilated patients in the COVID-19 era: a diagnostic and cost-benefit evaluation
doi: 10.1016/j.diagmicrobio.2022.115847
Figure Lengend Snippet: Quantitative result agreement between the FilmArray Pneumonia Plus panel (FA-PP) (in copies/mL) and standard of care culture (in CFU/mL) for all bacterial targets detected with FA-PP.
Article Snippet: One such approach is the BioFire® FilmArray® Pneumonia/Pneumonia plus Panel (FA-PP) (BioFire Diagnostics, LLC, Salt Lake City, UT), a multiplex PCR panel that allows detection of 15 bacteria commonly involved in VA-LRTBI, providing semiquantitative estimates of bacterial load and 7 genetic markers of antibiotic resistance (mecA/C and MREJ, blaCTX-M,blaKPC, blaVIM, blaOXA-48-like, blaIMP, blaNDM) This test has been extensively evaluated and proven to increase the diagnostic yield in LRTBI compared with standard culture-based methods , , , , , , , , , , , , , , , .
Techniques: